Imipenem/Cilastatin/Relebactam (IMI/REL) in Treatment of CRE Infections

Clinical trial NCT04785924 · WITHDRAWN

Trial details

NCT number: NCT04785924
Sponsor: Wake Forest University Health Sciences
Status: WITHDRAWN
Phase: Phase 4
Study type: INTERVENTIONAL

Carbapenem-Resistant Enterobacteriaceae Infection KPC Gram-Negative Bacterial Infections Antibiotic Resistant Infection

Start date: 2021-06-07
Primary completion: 2023-01-12
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.